BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10613189)

  • 1. Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes.
    Obrecht-Pflumio S; Chassat T; Dirheimer G; Marzin D
    Mutat Res; 1999 Oct; 446(1):95-102. PubMed ID: 10613189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro DNA and dGMP adducts formation caused by ochratoxin A.
    Obrecht-Pflumio S; Dirheimer G
    Chem Biol Interact; 2000 Jun; 127(1):29-44. PubMed ID: 10903417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Horseradish peroxidase mediates DNA and deoxyguanosine 3'-monophosphate adduct formation in the presence of ochratoxin A.
    Obrecht-Pflumio S; Dirheimer G
    Arch Toxicol; 2001 Dec; 75(10):583-90. PubMed ID: 11808918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes.
    Gautier J; Richoz J; Welti DH; Markovic J; Gremaud E; Guengerich FP; Turesky RJ
    Chem Res Toxicol; 2001 Jan; 14(1):34-45. PubMed ID: 11170506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system.
    Föllmann W; Lucas S
    Arch Toxicol; 2003 May; 77(5):298-304. PubMed ID: 12734645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a newly developed tester strain Salmonella typhimurium NM2009 for the study of metabolic activation of carcinogenic aromatic amines by rat liver microsomal cytochrome P-450 enzymes.
    Yamazaki H; Oda Y; Shimada T
    Mutat Res; 1992 Oct; 272(2):183-92. PubMed ID: 1383750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?
    Zepnik H; Pähler A; Schauer U; Dekant W
    Toxicol Sci; 2001 Jan; 59(1):59-67. PubMed ID: 11134544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines.
    Fouarge M; Mercier M; Poncelet F
    Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity studies of methyl-tert-butylether using the Ames tester strain TA102.
    Williams-Hill D; Spears CP; Prakash S; Olah GA; Shamma T; Moin T; Kim LY; Hill CK
    Mutat Res; 1999 Oct; 446(1):15-21. PubMed ID: 10613182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity tests with 6-acetyl-1,1,2,4,4,7-hexamethyltetraline and 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-gamma-2-benzopyr an.
    Api AM; San RH
    Mutat Res; 1999 Oct; 446(1):67-81. PubMed ID: 10613187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens.
    Kanode R; Chandra S; Sharma S
    Toxicol Mech Methods; 2017 Jun; 27(5):376-381. PubMed ID: 28325086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterocyclic amine mutagenicity/carcinogenicity: influence of repair, metabolism, and structure.
    Felton JS; Wu R; Knize MG; Thompson LH; Hatch FT
    Princess Takamatsu Symp; 1995; 23():50-8. PubMed ID: 8844795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial mutagenic evaluation of Luxabendazole, a new broad spectrum anthelmintic, with the Salmonella typhimurium His- and the Escherichia coli Tryp- reversion tests.
    Ortiz AI; Pollastrini MT; Barea M; Ordóñez D
    Mutagenesis; 1996 Jan; 11(1):27-31. PubMed ID: 8671711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carbendazim for gene mutations in the Salmonella/Ames plate-incorporation assay: the role of aminophenazine impurities.
    Sarrif AM; Arce GT; Krahn DF; O'Neil RM; Reynolds VL
    Mutat Res; 1994 Apr; 321(1-2):43-56. PubMed ID: 7510844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
    Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress.
    Palma N; Cinelli S; Sapora O; Wilson SH; Dogliotti E
    Chem Res Toxicol; 2007 Jul; 20(7):1031-7. PubMed ID: 17567156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.
    Sezzano P; Raimondi A; Arboix M; Pantarotto C
    Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.